相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer
Anthony Serritella et al.
CLINICAL CANCER RESEARCH (2022)
CTCF-mediated chromatin looping provides a topological framework for the formation of phase-separated transcriptional condensates
Ryanggeun Lee et al.
NUCLEIC ACIDS RESEARCH (2022)
Poly-glutamine-dependent self-association as a potential mechanism for regulation of androgen receptor activity
Carlos M. Roggero et al.
PLOS ONE (2022)
Loss and revival of androgen receptor signaling in advanced prostate cancer
Nicolo Formaggio et al.
ONCOGENE (2021)
Chromosome compartmentalization alterations in prostate cancer cell lines model disease progression
Rebeca San Martin et al.
JOURNAL OF CELL BIOLOGY (2021)
Phasing the intranuclear organization of steroid hormone receptors
Martin Stortz et al.
BIOCHEMICAL JOURNAL (2021)
Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling
Chenchu Lin et al.
ONCOGENE (2021)
Loop competition and extrusion model predicts CTCF interaction specificity
Wang Xi et al.
NATURE COMMUNICATIONS (2021)
Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapy
Tianfang Ma et al.
CANCER LETTERS (2021)
DNA-binding domain as the minimal region driving RNA-dependent liquid-liquid phase separation of androgen receptor
Junaid Ahmed et al.
PROTEIN SCIENCE (2021)
Glucocorticoid receptor condensates link DNA-dependent receptor dimerization and transcriptional transactivation
Filipp Frank et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer
Ken-ichi Takayama et al.
NATURE COMMUNICATIONS (2021)
Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate Cancer
Agus Rizal A. H. Hamid et al.
FRONTIERS IN ONCOLOGY (2021)
Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer
Tian Zhang et al.
CLINICAL GENITOURINARY CANCER (2020)
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer
Doris Hoeflmayer et al.
MOLECULAR ONCOLOGY (2020)
CTCF mediates chromatin looping via N-terminal domain-dependent cohesin retention
Elena M. Pugacheva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains
Amanda Khoury et al.
NATURE COMMUNICATIONS (2020)
Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity
Surendra Chaurasiya et al.
PLOS ONE (2020)
CDK-Regulated Phase Separation Seeded by Histone Genes Ensures Precise Growth and Function of Histone Locus Bodies
Woonyung Hur et al.
DEVELOPMENTAL CELL (2020)
The Role of Liquid-Liquid Phase Separation in the Compartmentalization of Cell Nucleus and Spatial Genome Organization
S. Razin et al.
BIOCHEMISTRY-MOSCOW (2020)
Unraveling the molecular interactions involved in phase separation of glucocorticoid receptor
Martin Stortz et al.
BMC BIOLOGY (2020)
The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer
Susmita G. Ramanand et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes
Xinzhe Yu et al.
MOLECULAR CELL (2020)
PML nuclear bodies and chromatin dynamics: catch me if you can!
Armelle Corpet et al.
NUCLEIC ACIDS RESEARCH (2020)
RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance
Jordan E. Vellky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Intrinsically disordered protein regions and phase separation: sequence determinants of assembly or lack thereof
Erik W. Martin et al.
EMERGING TOPICS IN LIFE SCIENCES (2020)
Spatial patterns of CTCF sites define the anatomy of TADs and their boundaries
Luca Nanni et al.
GENOME BIOLOGY (2020)
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer
Laura Cato et al.
CANCER CELL (2019)
Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular Condensates
Simon Alberti et al.
CELL (2019)
Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly
Sreejith J. Nair et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
The Role of Nuclear Receptors in Prostate Cancer
Masaki Shiota et al.
CELLS (2019)
Enhancer Features that Drive Formation of Transcriptional Condensates
Krishna Shrinivas et al.
MOLECULAR CELL (2019)
Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
Qin Feng et al.
FRONTIERS IN ONCOLOGY (2019)
Evaluating phase separation in live cells: diagnosis, caveats, and functional consequences
David T. McSwiggen et al.
GENES & DEVELOPMENT (2019)
A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome
Suhn Kyong Rhie et al.
NATURE COMMUNICATIONS (2019)
Hormone-control regions mediate steroid receptor-dependent genome organization
Francois Le Dily et al.
GENOME RESEARCH (2019)
Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression
Helmut Bonkhoff
PROSTATE (2018)
Crowding, Entropic Forces, and Confinement: Crucial Factors for Structures and Functions in the Cell Nucleus
R. Hancock
BIOCHEMISTRY-MOSCOW (2018)
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer
David Y. Takeda et al.
CELL (2018)
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
Srinivas R. Viswanathan et al.
CELL (2018)
Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide
Masaki Shiota et al.
PROSTATE (2018)
Imaging dynamic and selective low-complexity domain interactions that control gene transcription
Shasha Chong et al.
SCIENCE (2018)
Coactivator condensation at super-enhancers links phase separation and gene control
Benjamin R. Sabari et al.
SCIENCE (2018)
Paraspeckles: Where Long Noncoding RNA Meets Phase Separation
Archa H. Fox et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment
Ushashi C. Dadwal et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Mechanisms and Approaches for Overcoming enzalutamide Resistance in Prostate Cancer
Alexandra Vander Ark et al.
FRONTIERS IN ONCOLOGY (2018)
Genetics and biology of prostate cancer
Guocan Wang et al.
GENES & DEVELOPMENT (2018)
Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments
Jill J. Bouchard et al.
MOLECULAR CELL (2018)
Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II
Huasong Lu et al.
NATURE (2018)
The nuclear receptor superfamily: A structural perspective
Emily R. Weikum et al.
PROTEIN SCIENCE (2018)
Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains
Ann Boija et al.
CELL (2018)
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer (vol 174, pg 758, 2018)
David A. Quigley et al.
CELL (2018)
Liquid Nuclear Condensates Mechanically Sense and Restructure the Genome
Yongdae Shin et al.
CELL (2018)
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops
Yu Guo et al.
GENOME BIOLOGY (2018)
CTCF fences make good neighbours
Ivan Krivega et al.
NATURE CELL BIOLOGY (2017)
SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein
C. Geng et al.
ONCOGENE (2017)
Clinical relevance of androgen receptor alterations in prostate cancer
Emma Jernberg et al.
ENDOCRINE CONNECTIONS (2017)
Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
Daniel J. Crona et al.
CANCERS (2017)
A Phase Separation Model for Transcriptional Control
Denes Hnisz et al.
CELL (2017)
Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer
Jack Schalken et al.
BJU INTERNATIONAL (2016)
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
Isabel Coutinho et al.
ENDOCRINE-RELATED CANCER (2016)
The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
Greg L. Shaw et al.
EUROPEAN UROLOGY (2016)
CTCF-mediated topological boundaries during development foster appropriate gene regulation
Varun Narendra et al.
GENES & DEVELOPMENT (2016)
Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations
Phillippa C. Taberlay et al.
GENOME RESEARCH (2016)
Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
Chad G. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression
J. C. Zhao et al.
ONCOGENE (2016)
Androgen deprivation of prostate cancer: Leading to a therapeutic dead end
Arndt Katzenwadel et al.
CANCER LETTERS (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer (vol 161, pg 1215, 2015)
Dan Robinson et al.
CELL (2015)
Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions
Dario G. Lupianez et al.
CELL (2015)
Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization
Amandine Molliex et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Persistent androgen receptor addiction in castration-resistant prostate cancer
Michael T. Schweizer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
CTCF establishes discrete functional chromatin domains at the Hox clusters during differentiation
Varun Narendra et al.
SCIENCE (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer
Yuanyuan Qu et al.
SCIENTIFIC REPORTS (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
An update on enzalutamide in the treatment of prostate cancer
Axel S. Merseburger et al.
THERAPEUTIC ADVANCES IN UROLOGY (2015)
Liquid-Liquid Phase Separation in Biology
Anthony A. Hyman et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 (2014)
Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer
Kathryn E. Ware et al.
ENDOCRINE-RELATED CANCER (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer
Dayong Wu et al.
NUCLEIC ACIDS RESEARCH (2014)
GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
Bin He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate
W. Kim et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
Masis Isikbay et al.
HORMONES & CANCER (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers
Min S. Kim et al.
APMIS (2013)
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
Yingming Li et al.
CANCER RESEARCH (2013)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer
Javier Guerrero et al.
PROSTATE (2013)
An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
Manav Korpal et al.
CANCER DISCOVERY (2013)
A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
James D. Joseph et al.
CANCER DISCOVERY (2013)
AR Variant ARv567es Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer
Gang Liu et al.
NEOPLASIA (2013)
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2012)
A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression
Loukia G. Karacosta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Integrated analysis identifies a class of androgen-responsive genes regulated by short combinatorial long-range mechanism facilitated by CTCF
Cenny Taslim et al.
NUCLEIC ACIDS RESEARCH (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1
C. Li et al.
ONCOGENE (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
Xiaotun Zhang et al.
PLOS ONE (2011)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
CTCF mediates long-range chromatin looping and local histone modification in the β-globin locus
Erik Splinter et al.
GENES & DEVELOPMENT (2006)
BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase
JE Kwon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antiandrogens prevent stable DNA-binding of the androgen receptor
P Farla et al.
JOURNAL OF CELL SCIENCE (2005)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain
IJ McEwan
ENDOCRINE-RELATED CANCER (2004)
Differential expression of the estrogen receptor beta (ERβ) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma
T Fixemer et al.
PROSTATE (2003)
Androgen receptor as a target in androgen-independent prostate cancer
SP Balk
UROLOGY (2002)
Position-effect protection and enhancer blocking by the chicken β-globin insulator are separable activities
F Recillas-Targa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
